Quantinno Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Quantinno Capital Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,453	Closed	-$653K	–	3484
2026 Q1	$653K	Buy	32,453 +3,297	+11%	+$53.1K	﹤0.01%	2516
2025 Q4	$471K	Buy	29,156 +14,998	+106%	+$199K	﹤0.01%	2493
2025 Q3	$172K	Buy	+14,158	New	+$196K	﹤0.01%	2802

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quantinno Capital Management's KALV Position: Q2 2026 in Review

Quantinno Capital Management sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 32,453 shares — an estimated $653K sold.

Quantinno Capital Management first reported a position in KALV in Q3 2025 and held it in 3 quarters. The position peaked at $653K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Quantinno Capital Management reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Quantinno Capital Management sold 32,453 KalVista Pharmaceuticals shares in Q2 2026, an estimated $653K.
Quantinno Capital Management first reported a position in KalVista Pharmaceuticals in Q3 2025 and held it in 3 quarters.
Quantinno Capital Management's KalVista Pharmaceuticals position peaked at $653K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.